Pulmonx, Inc. Reports New Publication Confirms Efficacy of Emphysema Treatment

5/11/2012 10:48:15 AM

PESEUX, Switzerland--(BUSINESS WIRE)--Pulmonx, an emerging leader in interventional pulmonology, announced today that the European Respiratory Journal has published the results of the Chartis Multi-Centre study. The study is the first to combine the Chartis Pulmonary Assessment System and Zephyr EBV treatment for patients with advanced emphysema. The published results of the study demonstrate that in patients who achieve volume reduction post Endobronchial Valve treatment, the majority get clinically significant responses in lung function, exercise tolerance and quality of life measures. After detailed review of the U.S. and European VENT data, a much broader profile of patient characteristics was identified for potential inclusion; including patients that would have been excluded in the previous studies.

Read at BioSpace.com

Read Article at

Related Companies

News Categories

• BioSpace.com

• Pulmonx, Inc.

• Medical Devices

• Medical Dev. & Diag. - Research